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ing throughout infancy, but FUF are widely used and thus 
the outdated current FUF standard should be revised. Like IF, 
FUF serve as breast milk substitutes; hence their marketing 
should respect appropriate standards. The compositional re-
quirements for FUF for infants from 6 months onwards pre-
sented here were unanimously agreed upon. For some nu-
trients, the compositional requirements for FUF differ from 
those of IF due to differing needs with infant maturation as 
well as a rising contribution of an increasingly diversified diet 
with advancing age. FUF should be fed with adequate com-
plementary feeding that is also appropriate for partially 
breastfed infants. FUF could be fed also after the age of 1 
year without safety concerns, but different compositional re-
quirements should be applied for optimal, age-adapted 
milk-based formulations for young children used only after 
the age of 1 year. This has not been considered as part of this 
review and should be the subject of further consideration. 
 Copyright © 2012 S. Karger AG, Basel 
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 Abstract 
 The follow-up formula (FUF) standard of Codex Alimentarius 
adopted in 1987 does not correspond to the recently updat-
ed Codex infant formula (IF) standard and current scientific 
knowledge. New Zealand proposed a revision of the FUF Co-
dex standard and asked the non-profit Early Nutrition Acad-
emy, in collaboration with the Federation of International 
Societies for Paediatric Gastroenterology, Hepatology, and 
Nutrition (FISPGHAN), for a consultation with paediatric nu-
trition experts to provide scientific guidance. This global ex-
pert group strongly supports breastfeeding. FUF are consid-
ered dispensable because IF can substitute for breastfeed-
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 Background 
 The Food and Agriculture Organisation of the United 
Nations (FAO) and the World Health Organisation 
(WHO) jointly created the Codex Alimentarius Com-
mission (CAC) in 1963, aimed at developing food stan-
dards, guidelines, and related texts such as codes of prac-
tice under the Joint FAO/WHO Food Standards Pro-
gramme (www.codexalimentarius.net). The key goals 
are to protect the health and well-being of consumers, to 
ensure fair practices in the food trade, and to promote 
coordination of food standards work undertaken by in-
ternational governmental and non-governmental organ-
isations  [1] . In the fall of 2012, Codex Alimentarius had 
185 member nations and one member organisation cov-
ering 99% of the world’s population  [2] . Codex Alimen-
tarius develops and publishes a large number of stan-
dards addressing food quality and safety that are of key 
importance for protecting public health and fair trade 
globally.
 The Codex Standard 72 on Infant Formula was origi-
nally published in 1981, and a thoroughly revised version 
of this, i.e.  Standard for infant formula and formulas for 
special medical purposes intended for infants, was adopted 
in 2007  [3] . The adoption of the updated standard was 
facilitated by recommendations on compositional re-
quirements provided by an international expert group 
coordinated by the European Society for Paediatric Gas-
troenterology, Hepatology, and Nutrition (ESPGHAN, 
www.espghan.org)  [1] , which were largely adopted in the 
Codex standard.
 In 1987, the CAC also adopted a standard for follow-up 
formula (FUF)  [4] . FUF was defined in this Codex stan-
dard as ‘a food prepared from the milk of cows or other 
animals and/or other constituents of animal and/or plant 
origin, which have been proved to be suitable for infants 
from the 6th month on and for young children’.  [4] . How-
ever, the concepts and compositional data in this stan-
dard adopted in 1987, i.e. 25 years ago, do not correspond 
to those laid down in the recently updated Codex stan-
dard on infant formula (IF)  [3] and current scientific 
knowledge  [1] . Therefore, in 2010, the government of New 
Zealand proposed to the Codex Committee on Nutrition 
and Foods for Special Dietary Uses (CCNFSDU) the need 
to discuss the revision of the standard for FUF, and the 
CCNFSDU agreed to consider this proposal  [5] . In the 
following year (2011), the CCNFSDU noted support for 
the review of the FUF standard but, due to time con-
straints with the agenda, did not make a decision on 
whether or not such a review should be undertaken  [6] . 
In 2012, New Zealand renewed the proposal for a review 
of the FUF standard  [7] .
 In preparation for a possible review, the government 
of New Zealand asked the Early Nutrition Academy 
(ENA) to provide guidance on the compositional re-
quirements for FUF for infants aged 6 months and older, 
based on current scientific and paediatric knowledge 
and in consultation with an international group of pae-
diatric nutrition experts. The ENA is a non-profit soci-
ety that was created by and represents the partners of 
international research projects funded by the European 
Commission and the Australian National Health and 
Medical Research Council (www.early-nutrition.org). 
The purpose of the society is to promote the knowledge 
of human nutrition in early life, to stimulate research in 
this and related areas of science, nutrition, and health, 
and to disseminate such knowledge at scientific meet-
ings and elsewhere. The ENA, which represents a large 
number of researchers from universities across Europe, 
Australia, and the USA, was granted observer status at 
Codex Alimentarius in 2012 by the Executive Commit-
tee of the CAC.
 The ENA, in close collaboration with the Federation 
of International Societies on Paediatric Gastroenterolo-
gy, Hepatology, and Nutrition (FISPGHAN), ESPGHAN, 
and its other member societies, identified knowledgeable 
experts in the area of paediatric nutrition and health 
from all five continents and invited them to participate 
in an electronic exchange of information and in a physi-
cal meeting held on November 14–15, 2012, prior to the 
FISPGHAN World Congress on Paediatric Gastroenter-
ology, Hepatology, and Nutrition in Taipei, Taiwan. Cri-
teria for participation included expertise in paediatric 
nutrition and active contributions to international scien-
tific societies or advisory bodies dealing with paediatric 
nutrition. Preference was given to experts that had al-
ready decided to attend the FISPGHAN World Congress 
in Taipei to avoid additional travel costs. In order to en-
sure that experts were in a position to provide objective 
and disinterested scientific advice, all participating ex-
perts submitted a written declaration of personal and 
non-personal (institutional) interests which were care-
fully reviewed and discussed. The expert participants are 
listed as authors of this manuscript. In addition, two ob-
servers from the government of New Zealand participat-
ed in the meeting in Taipei (Ms. Charlotte Channer and 
Ms. Jenny Reid). Based on a considered review of the 
available evidence and a thorough discussion, the expert 
group unanimously  agreed on the conclusions reported 
below.
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 General Considerations and Definitions 
 The expert group strongly supports breastfeeding as 
the normal and ideal form of infant feeding, which should 
be actively promoted, protected, and supported  [8–10] . 
Based on the results of an expert consultation  [11] , the 
WHO has recommended: ‘As a global public health rec-
ommendation, infants should be exclusively breastfed for 
the first 6 months of life to achieve optimal growth, devel-
opment, and health. Thereafter, to meet their evolving nu-
tritional requirements, infants should receive nutrition-
ally adequate and safe complementary foods while breast-
feeding continues for up to 2 years of age or beyond.’  [12] .
 Infants who cannot be fed at the breast, or should not 
receive breast milk for medical reasons (e.g. due to galac-
tosaemia), or for whom breast milk is not available should 
receive IF that are intended to serve as a substitute for 
breast milk  [5] . An IF serves ‘to satisfy, by itself, the nu-
tritional requirements of infants during the first months 
of life up to the introduction of appropriate complemen-
tary feeding’  [3] . IF can continue to serve as a breast milk 
substitute for the entire duration of the first year of life 
and even beyond, although cow’s milk (or other suitable 
milks) can also be used in the second year of life  [13, 14] .
 FUF have been previously defined by Codex Alimen-
tarius as foods ‘intended for use as a liquid part of the 
weaning diet for the infant from the 6th month on and 
for young children’  [4] , i.e. from the age of 6 up to 36 
months. During the first year of life, both IF and FUF 
serve to substitute for breast milk; therefore, the market-
ing of both groups of products should respect the Inter-
national Code of Marketing of Breast Milk Substitutes 
 [15] , the Global Strategy for Infant and Young Child 
Feeding  [12] , and World Health Assembly resolution 
WHA54.2 (2001). The expert group acknowledges that 
FUF are dispensable because IF can substitute for breast 
milk during the whole duration of the first year of life. 
However, currently FUF are widely used in many popula-
tions, and in some countries the large majority of infants 
receive FUF during the second half of the first year of life 
 [7] . Therefore, it is recommended that Codex Alimentar-
ius updates its FUF standard and provides guidance on 
the appropriate composition of FUF following currently 
available scientific information. FUF are meant to be 
used only in older infants after timely introduction of
appropriate complementary feeding, with increasing 
amounts and diversity of complementary foods over time 
 [12, 13] . While the global population recommendation of 
the WHO is exclusive breastfeeding for 6 months, intro-
duction of complementary feeds during a range of ages 
from the 5th to the 7th month has been considered an op-
tion for infants in affluent populations with high stan-
dards of hygiene and low risks of infection  [16–18] and is 
widely practiced  [19] . The expert group has provided rec-
ommendations for compositional requirements of FUF 
for use in infants generally from the age of 6–12 months, 
but not prior to the introduction of complementary feed-
ing. The expert group considered that FUF must be able 
to serve as the dominant food source at the beginning of 
introducing complementary feeding when FUF may pro-
vide more than 90% of an infant’s energy intake. There-
fore, in many aspects the recommended composition of 
FUF follows the current standard for IF  [3] . The available 
evidence from studies addressing the specific nutrient 
needs of infants aged 6–12 months is more limited than 
for infants during the first months of life; however, there 
is evidence that the compositional requirements for FUF 
differ for some nutrients from those of IF due to differing 
needs with infant maturation as well as a rising contribu-
tion of an increasingly diversified diet with advancing 
age. The expert group based its recommendations on the 
concept that FUF will be fed along with complementary 
foods of adequate composition that would also suffice to 
meet the needs of a partially breastfed infant. Thus, FUF 
is not meant to compensate for inadequate complemen-
tary feeds, but rather appropriate complementary feeding 
regimens need to be supported in the interest of all in-
fants, as per the norm of infants that are partially breast-
fed after the age of 6 months. FUF with a composition as 
recommended here could be continued for use after the 
age of 1 year without safety concerns. However, it is em-
phasized that different compositional requirements 
should be applied for optimal, age-adapted milk-based 
formulations for young children used only from the age 
of 1 year onwards. The expert group has not considered 
the specific nutritional requirements of young children 
(from the age of 12 months up to 36 months) as part of 
this review paper and acknowledges that the composi-
tional requirements of such products (also referred to as 
‘toddler milks’ or ‘growing-up milks’)  [20, 21] should be 
the subject of further expert consideration.
 Recommendations for FUF Composition 
 FUF is a food prepared from the milk of cows or other 
animals and/or other constituents of animal and/or plant 
origin that are suitable for infants from the timely intro-
duction of complementary feeding onwards. The nutri-
tional safety and adequacy of FUF and its components 
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should be based on scientifically accepted evidence. The 
expert group agrees with previously published comments 
that the adequacy and safety of dietary products for in-
fants should be determined by a thorough evaluation of 
its effects on physiological, biochemical, and functional 
outcomes in infants  [1, 22–24] . It also supports the con-
clusion that dietary products for infants should only con-
tain components in amounts that serve a nutritional pur-
pose or provide another benefit. Minimum and maxi-
mum values of nutrient contents in FUF are suggested 
here with the goal to provide safe and nutritionally ade-
quate products that meet the nutritional requirements of 
generally healthy infants  [1] . Guidance upper levels are 
proposed if the available evidence is considered insuffi-
cient for a science-based quantitative risk assessment in 
infants aged about 6–12 months. Minimum, maximum, 
and guidance upper level values refer to the total nutrient 
contents of products as prepared ready for consumption 
according to the instructions of the manufacturer. This 
expert group recommends that FUF contain per 100 kcal 
the nutrient contents as listed in  table 1 . This group rec-
ognizes that nutrient supply and status among infants 
and young children differs in various parts of the globe, 
particularly for micronutrients, and thus the require-
ments of specific nutrient contents in FUF might need to 
be set different from these recommendations in some 
countries or regions. In particular, the use and composi-
tion of FUF in different geographic areas should take into 
account national or regional micronutrient supplementa-
tion programs to avoid excessive intakes. Below we pro-
vide some comments which only address issues where 
recommendations for FUF are made that differ from the 
established compositional requirements of IF  [1, 3] .
Table 1. P roposed compositional requirements
Component Mini-
mum
Maxi-
mum
Guidance
upper 
level
FUF
Energy, kcal/100 ml 60 70
Proteins
Cow’s milk protein, g/100 kcal 1.7* 2.5*
Soy protein isolates, g/100 kcal 2.1* 2.5*
Lipids
Total fat, g/100 kcal 4.4 6.0
Linoleic acid, g/100 kcal 0.3 1.4
-Linolenic acid, mg/100 kcal 50 NS
Ratio linoleic/-linolenic acids 5:1 15:1
Lauric + myristic acids, % of fat NS 20
Trans fatty acids, % of fat NS 3
DHA1, % of fat NS 1.0*
Erucic acid, % of fat NS 1
Phospholipids, mg/100 kcal 550
Carbohydrates
Total carbohydrates, g/100 kcal 9.0 14.0
Vitamins
Vitamin A2, g RE/100 kcal 60 180
Vitamin D3, g/100 kcal 1 4.5*
Vitamin E4, mg -TE/100 kcal 0.53 5
Vitamin K, g/100 kcal 4 27
Thiamin, g/100 kcal 60 300
Riboflavin, g/100 kcal 80 500
Niacin5, g/100 kcal 300 1,500
Vitamin B6, g/100 kcal 35 175
Vitamin B12, g/100 kcal 0.1 1.5
Pantothenic acid, g/100 kcal 400 2,000
Folic acid, g/100 kcal 10 50
Vitamin C, mg/100 kcal 10 70
Biotin, g/100 kcal 1.5 10
Minerals and trace elements
Iron (formula based on cow’s milk
protein), mg/100 kcal 1.1* 1.9*
Iron (formula based on soy protein
isolates), mg/100 kcal 1.3* 2.5*
Calcium, mg/100 kcal 50 180*
Phosphorus, mg/100 kcal 25 NS*
Magnesium, mg/100 kcal 5 15
Sodium, mg/100 kcal 20 60
Chloride, mg/100 kcal 50 160
Potassium, mg/100 kcal 60 180
Manganese, g/100 kcal 100*
Iodine, g/100 kcal 10 60
Selenium, g/100 kcal 1 9
Copper, g/100 kcal 35 250
Zinc, mg/100 kcal 0.5 1.5
Other substances 
Choline, mg/100 kcal 7 150*
L-Carnitine, mg/100 kcal 1.2 NS
Taurine, mg/100 kcal NS 12
Total added nucleotides, mg/100 kcal 0 10.8*
N S = Not specified.
1 The content of DHA (22:6n–3) shall be at least as high as the content 
of EPA (20:5n–3).
2 1 g RE (retinol equivalent) = 1 g all-trans retinol = 3.33 IU vitamin 
A. Retinol contents shall be provided by preformed retinol, while any con-
tents of carotenoids should not be included in the calculation and declara-
tion of vitamin A activity.
3 1 mg -TE (-tocopherol equivalent) = 1 mg D--tocopherol.
4 The vitamin E content shall be at least 0.5 mg -TE/g PUFA, using the 
following factors of equivalence to adapt the minimal vitamin E content to 
the number of fatty acid double bonds in the formula: 0.5 mg -TE/g lino-
leic acid (18:2n–6); 0.75 mg -TE/g -linolenic acid (18:3n–3); 1.0 mg -
TE/g arachidonic acid (20:4n–6); 1.25 mg -TE/g EPA (20:5n–3); 1.5 mg 
-TE/g DHA (22:6n–3).
5 Niacin refers to preformed niacin.
* Levels that are different from those in the Codex Standard for Infant 
Formula and Formulas for Special Medical Purposes Intended for Infants 
(Codex Stan 72-1981) [3].
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 Energy Density 
 Studies with current methodology have revealed an 
average energy density of human milk of about 65 kcal/
100 ml  [25, 26] . A dietary energy density markedly high-
er than typically found in human milk may increase the 
total energy intake and lead to a higher than desirable 
weight gain  [1, 27] . A high weight gain of healthy children 
during the first 2 years is not desirable since it is associ-
ated with a markedly increased risk of later obesity and 
related diseases  [12, 28, 29] . Therefore, the energy density 
of FUF should be the same as in IF, i.e. FUF prepared 
ready for consumption in accordance with the instruc-
tions of the manufacturer shall contain per 100 ml not 
less than 60 kcal (250 kJ) and not more than 70 kcal (295 
kJ) of energy. This energy density is appropriate to sup-
port physiological weight gain in healthy infants who also 
receive adequate complementary feeding.
 Protein 
 The average daily protein intake of breastfed infants at 
age 6 months has been estimated as 0.95 g/kg body weight 
 [30] . Population reference intakes for the dietary protein 
intake per day calculated to meet the needs of basically 
all infants in the population with an adequate safety mar-
gin have been considered as 1.31 g protein/kg bodyweight 
at age 6 months and 1.14 g/kg at 12 months by the WHO/
FAO/UNU  [31] and by EFSA  [32] , whereas recent recom-
mendations by some other bodies have set slightly lower 
dietary reference values of protein of 1.1–1.2 g/kg at 6 
months [reviewed in  32 ]. To safely cover total protein 
needs at a daily energy intake of 80 kcal/kg, a protein sup-
ply of 1.31 g at 6 months would result in a protein density 
of 1.64 g protein/100 kcal, while a protein supply of 1.14 g 
at 12 months would result in a protein density of 1.43 g 
protein/100 kcal. It is recommended to set the minimum 
content of cow’s milk protein in FUF at 1.65 g/100 kcal, 
based on a good protein quality with an adequate content 
of bioavailable essential amino acids. Consistent with the 
IF standard, protein content should be calculated based 
on the established nitrogen conversion factor of 6.25  [3] .
 High infant milk protein intakes during the first year 
of life that markedly exceed metabolic requirements were 
shown to lead to excessive weight gain which can increase 
the risk of later obesity and associated diseases  [33–39] . 
Therefore, high milk protein intakes provided with for-
mulae for infants should be avoided. While mature hu-
man milk at an infant age of 6 months provides about 5% 
of the energy content as protein, the protein content of 
mixed family foods and complementary foods is typical-
ly in the order of 15–20% of energy and most infants get-
ting complementary feeding have protein intakes far 
above the requirements  [38–41] . We recommend that the 
maximum protein content in FUF should not exceed 
150% of the minimum content, i.e. 2.5 g/100 kcal which 
equals about 10% of the energy content. This maximum 
protein content would also cover additional protein needs 
in case of catch-up growth.
 Based on concerns of lower bioequivalence of soy pro-
tein isolate, the minimum protein content of IF based on 
soy protein isolates has been set in the IF standard at 1.25 
times the minimum of cow’s milk-based IF while the 
maximum levels set are the same  [3] , although the scien-
tific evidence to justify this choice is limited. To achieve 
consistency with the IF standard, the minimum and 
maximum protein contents in FUF based on soy protein 
isolate should be set at 2.05 g/100 kcal and 2.5 g/100 kcal, 
respectively.
 If proteins other than cow’s milk and soy proteins are 
used in FUF, their suitability and adequate minimum 
and maximum amounts should be determined based on 
scientific evidence, including, where appropriate, clinical 
trials. Higher minimum protein levels than recommend-
ed for cow’s milk protein may be needed for other protein 
sources to correct for potential lower contents of indis-
pensable amino acids and potential lesser digestibility 
and biological value of the nitrogen content  [42, 43] . De-
termination of the protein efficiency ratio in rats is of 
limited value for evaluating the suitability of proteins for 
infant feeding, and hence the protein efficiency ratio is 
not recommended for this purpose; rather the protein di-
gestibility-corrected amino acid score (PDCAAS) should 
be considered  [31] .
 The use of IF based on hydrolysed protein during the 
first 4–6 months of life was associated with risk reduction 
of infant and childhood allergy and infant cow’s milk 
protein allergy in infants with a family history of allergy 
 [44, 45] . There is no indication of a protective effect of the 
further use of hydrolysed protein in FUF during the sec-
ond half year of infancy when complementary feeding 
usually provides intact proteins from cow’s milk and oth-
er sources. Therefore, no value is provided here for hydro-
lysed protein in FUF.
 The recommended minimum content of indispens-
able and conditionally indispensable amino acids in FUF 
( table 2 ) is based on the data on amino acid content in hu-
man milk reference protein and the recommended mini-
mum cow’s milk protein content of 1.65 g/100 kcal, anal-
ogous to the approach adopted for IF  [1, 3] . The expert 
group notes that new data on infant amino acid require-
ments are emerging  [46–48] , which may require revised 
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definitions of minimum contents of non-dispensable and 
conditionally indispensable amino acids in IF and FUF 
in the future. Maximum levels of amino acid contents in 
FUF do not need to be set given that maximum levels of 
total protein are established.
 Lipids 
 The lipid content and composition of FUF should gen-
erally follow the standards set for IF  [1, 3] . A total fat con-
tent of 4.4–6.0 g/100 kcal equivalent to   40–55% of the 
energy content similar to typical human milk values is 
recommended in order to allow for the same complemen-
tary feeding concepts to be applied for infants that are 
partially breastfed or partially fed IF or FUF. Also, the 
requirements for essential fatty acid contents should be 
similar to those set for IF  [1, 3] .
 For some aspects of fat quality in FUF a precautionary 
approach is recommended in the absence of specific evi-
dence for the second half of the first year of life; therefore, 
the established concepts for IF should be followed  [3] . In 
consideration of the potential untoward effects of lauric 
acid and myristic acid on serum cholesterol and lipopro-
tein concentrations, the sum of both of these fatty acids 
should not exceed 20% of the total fat contents.  Trans fat-
ty acids have no known nutritional benefit for infants, but 
may induce untoward biological effects. Commercial hy-
drogenated oils and fats should not be used in FUF. The 
 trans fatty acid content of FUF should not exceed 3% of 
the total fatty acids, which allows for the use of reasonable 
amounts of milk fat from cows and other ruminant ani-
mals in FUF. Erucic acid has no known nutritional ben-
efits for infants but was associated with potential myocar-
dial toxicity in animals. Based on a precautionary ap-
proach, erucic acid contents acids in FUF should not 
exceed 1% of the total fat content.
 The Codex standard for IF allows an optional supply of 
docosahexaenoic acid (22: 6n–3, DHA) up to 0.5% of the 
fat content which must be matched with an at least equal 
supply of arachidonic acid (20: 4n–6)  [3] . The endogenous 
synthesis of DHA from the n–3 fatty acid precursor   -
linolenic acid is limited in humans, and the degree of 
DHA synthesis varies considerably with inter-individual 
genetic differences in the fatty acid desaturase gene cluster 
 [49, 50] . The provision of preformed DHA during the first 
year of life has been associated with benefits for visual and 
brain development and immune response, but other stud-
ies have not demonstrated benefit  [51, 52] . Addition of 
DHA in an amount of 1% of the total fatty acids to for-
mula for preterm infants has not led to untoward effects 
in a very large clinical trial  [53, 54] , and there is no reason 
to limit the content in FUF to a lower amount. During the 
first few months of life the ability to maintain arachidon-
ic acid stores from endogenous synthesis increases  [55] . 
Moreover, dietary preformed arachidonic acid is provided 
by a variety of complementary foods during the second 
half of the first year of life. The provision of oily fish with 
complementary feeds can provide high intakes of DHA 
with little supply of arachidonic acid, without any indica-
tion of adverse effects. In a randomized clinical trial, sup-
plementation of infants with 500 mg/day of an n–3 fatty 
acid-rich tuna fish oil supplement providing DHA with-
out appreciable amounts of arachidonic acid from the age 
of 6 months onwards did not show untoward effects  [56, 
57] . Therefore, it is considered unnecessary to set a re-
quirement for added arachidonic acid in FUF that pro-
vides DHA. However, the expert group recommends lim-
iting the content of eicosapentaenoic acid (20: 5n–3, EPA), 
a direct metabolic competitor of arachidonic acid, to an 
amount not exceeding the content of DHA in FUF.
 For IF fed from birth, a maximum phospholipid con-
centration of 300 mg/100 kcal (equivalent to about 2 g/l) 
has been set following the precautionary approach. For 
older infants at the age of FUF feeding, there are few con-
Table 2. P roposed values for minimum amino acid contents in 
FUF
Amino acid g/100 g protein mg/100 kcal
Cystine 2.1 34.7
Histidine 2.3 38.0
Isoleucine 5.1 84.2
Leucine 9.4 155.1
Lysine 6.3 104.0
Methionine 1.4 23.1
Phenylalanine 4.5 74.3
Threonine 4.3 71.0
Tryptophan 1.8 29.7
Tyrosine 4.2 69.3
Valine 5 82.5
F UF should contain per 100 kcal an available quantity of each 
of the amino acids listed at least equal to that contained in the 
reference protein, as shown in this table. 
For calculation purposes, the concentrations of phenylalanine 
and tyrosine may be added together if the phenylalanine-to-tyro-
sine ratio is in the range of 0.7–1.5 to 1, and the concentrations of 
methionine and cysteine may be added together if the methio-
nine-to-cysteine ratio is in the range of 0.7–1.5 to 1. It is noted that 
new data on infant amino acid requirements are emerging [46–
48], which may require revised definitions of minimum contents 
of non-dispensable and conditionally indispensable amino acids 
in IF and FUF in the future.
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cerns regarding the provision of phospholipids with usu-
al complementary feeds which provide considerable 
amounts of phospholipids. For example, infants will con-
sume about 3.5 g phospholipids with one hen’s egg. Re-
search into the roles of phospholipids in human milk fat 
globules indicates potential benefits of adding certain 
phospholipids to FUF  [58–60] , in addition to solubilizing 
lipophilic compounds and acting as a source of long-
chain polyunsaturated fatty acids. Therefore, a concen-
tration of 550 mg/100 kcal (equivalent to about 3.5 g/l) is 
recommended as the guidance upper level.
 Carbohydrates 
 Total carbohydrate contents in FUF equal to those set 
for IF are recommended. Lactose, glucose polymers, and 
precooked and gelatinized starches that are gluten free by 
nature are the preferred carbohydrate sources in FUF. 
Starches may provide up to 30% of the total carbohy-
drates. Fructose and sucrose are provided with comple-
mentary feeds and may also be provided with FUF, but in 
line with previous scientific evaluations it is recommend-
ed that the sum of saccharose (sucrose) and fructose 
should not exceed 20% of the total carbohydrate content 
in FUF  [61] , i.e. at a maximum carbohydrate content of 
14 g/100 kcal no more than a maximum of 11.2 % of en-
ergy which is similar to the guidance provided by the 
WHO for the general population  [62] .
 Vitamins 
 There is lack of sufficient evidence that would allow 
setting different compositional requirements for vita-
mins in FUF as compared to IF. Contents of lipid- and 
water-soluble vitamins in FUF equal to those set for IF 
are recommended, except for vitamin D.
 Recent data show that a significant number of infants 
and young children in different parts of the world have a 
suboptimal or deficient vitamin D status  [63–68] which 
has prompted efforts to improve vitamin D supply. The 
expert group recommends a higher maximum vitamin D 
content for FUF than previously established for in IF, 
which may contribute to improving vitamin D status and 
associated health outcomes. EFSA determined tolerable 
upper intake level (UL) for vitamin D of 1,000 IU for the 
whole duration of the first year of life while acknowledg-
ing a limited evidence base for the approach chosen  [60] . 
In contrast, the Institute of Medicine determined an age-
specific UL for vitamin D for infants aged 6–12 months of 
1,500 IU/day  [69] . Based on the latter, age-specific UL, and 
an assumed maximum FUF intake of 800 kcal/day, the 
recommended maximum value for vitamin D content in 
FUF is 4.5   g/100 kcal (180 IU/100 kcal). It is emphasized 
that vitamin D contents in FUF below this maximum val-
ue should be chosen in populations where additional vi-
tamin D supplementation programs are implemented.
 Minerals and Trace Elements 
 Iron 
 Body stores of iron present at birth cover most of the 
iron needs of healthy infants during the first half year of 
life, when iron absorption and dietary iron requirements 
are low  [70] . In contrast, at the age of about 6 months en-
dogenous body iron stores tend to be exhausted. At the 
age of 6–12 months, infants have high daily iron require-
ments of about 0.9–1.3 mg/kg body weight or about 8–11 
mg/day  [71–75] . To meet daily iron needs of 0.9 or 1.3 mg/
kg body weight from FUF at an energy intake of 80 kcal/
kg/day, an iron content of 1.1 or 1.6 mg/100 kcal, respec-
tively, is required. The feeding of formula with an iron 
content of 1.9 mg/100 kcal from 6 to 12 months of age did 
not show adverse effects and was considered safe  [76] . The 
expert group recommends an iron content in FUF based 
on cow’s milk ranging from 1.1 to 1.9 mg/100 kcal. Since 
the bioavailability of iron in FUF based on soy protein 
isolates may be reduced by phytic acid content, a higher 
minimum iron content of 1.3 mg/100 kcal and a maxi-
mum content of 2.5 mg/100 kcal are suggested for FUF 
based on soy protein isolates, based on the same concepts 
as applied in the Codex IF standard  [3] .
 Other Minerals and Trace Elements 
 The expert group recommends that FUF contain the 
same amounts of most other minerals and trace elements 
as set for IF, with the exception of calcium, phosphorus, 
manganese, and copper.
 Infants aged 6–12 months have achieved a greater de-
gree of renal maturation, and the UL of calcium of 1,500 
mg/day is higher during the second half of the first year 
of life than for infants from birth to age 6 months  [77] . 
Based on an assumed maximum intake of FUF of 800 
kcal/day, a maximum level for the calcium content in FUF 
of 180 mg/100 kcal is recommended. No UL for phospho-
rus has been set by the Institute of Medicine and by EFSA, 
because there are no data relating to adverse effects of 
phosphorus intake for most of the first year of life except 
for a sensitivity of very young infants  [78, 79] . Therefore, 
no maximum or guidance upper level for phosphorus is 
determined. Given that complementary foods can pro-
vide high and variable intakes of calcium and phosphorus, 
it is considered unreasonable to require a strict limitation 
of the calcium/phosphorus ratio in FUF.
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 The manganese content levels in IF are not based on 
firm evidence of quantitative requirements of infants but 
on human milk concentrations and indications of poten-
tial adverse effects of very high intakes in newborn ani-
mals  [1] . During the complementary feeding period, vari-
able and sometimes rather high supplies, e.g. from wheat, 
soybeans, sunflower seeds, and other seeds as well as 
nuts, occur, without any indication of untoward effects. 
No UL for manganese intake has been established  [80] . 
The expert group sees no need to define minimum con-
tents of manganese in FUF. Following the precautionary 
principle, a guidance upper level of 100   g/100 kcal is 
recommended.
 The liver toxicity of higher copper intakes is particu-
larly high during the first few weeks and months of life 
 [81–83] , which has prompted setting of a guidance upper 
level of 120   g copper/100 kcal for IF that can be fed as the 
sole source of nutrition from birth. At older infant ages, 
the infant liver appears to be far more resistant to the ad-
verse effects of copper. In a controlled trial, the provision 
of about 2,000   g Cu/day to infants from 3 to 9 months of 
age did not show any signs of adverse effects  [84] . This in-
take would be equivalent to a daily intake of about 400   g 
Cu/kg at the age of 3 months or about 500   g Cu/100 kcal 
at an energy intake of 80 kcal/kg. Moreover, in infant rhe-
sus monkeys, feeding a formula containing 6.6 mg Cu/l 
was not associated with any clinical evidence of copper 
toxicity  [85] . Therefore, a guidance upper level for copper 
in FUF of 250   g Cu/100 kcal is suggested.
 Other Substances 
 Choline 
 The minimum choline content of 7 mg/100 kcal set for 
IF is also recommended for FUF. No major safety concerns 
exist and no adverse effects of higher choline intakes have 
been documented in infants. If an infant would consume 
2 hen’s eggs as part of complementary feeding it would get 
a choline supply in the order of 200–250 mg. A guidance 
upper level of 150 mg/100 kcal is proposed for FUF, in line 
with the proposed maximum phospholipid content of 550 
mg/100 kcal, considering that a major part of added phos-
pholipids may be provided as phosphatidylcholine.
 Myo-Inositol 
 Myo-inositol can be readily synthesized in the human 
body, and there is no concern about toxicity with respect 
to usual intakes from food sources. Therefore, the expert 
group considers the setting of minimum a guidance of 
upper level for myo-inositol contents in FUF for older in-
fants unnecessary.
 L -Carnitine 
 Adoption of the established requirements for IF also 
for FUF is recommended.
 Taurine 
 In line with previous expert consultations  [2,3] , the 
expert group sees no need for mandatory addition of tau-
rine to FUF but recommends a maximum content of 12 
mg/100 kcal.
 Nucleotides 
 The addition of nucleotides to formulae for infants has 
been associated with proposed benefits of immune and 
antibody responses to vaccination, protection against di-
arrhoea, benefits for gut microbiota composition, and in-
fant growth promotion  [86–89] . Nucleotide concentra-
tions in formula ranging from 1.9 to 10.8 mg/100 kcal 
have been evaluated  [88] . Older infants that consume 
FUF are also exposed to nucleotide supplies from a vari-
ety of complementary foods and are considered less sensi-
tive to conceivable untoward effects than neonates are. 
Therefore, a maximum nucleotide content of 10.8 mg/100 
kcal is suggested.
 Further Considerations 
 While the recommendations made here are based on 
current understanding of the available evidence, it is rec-
ognized that future scientific progress will necessitate re-
visiting and updating these compositional consider-
ations. Modifications of FUF beyond established stan-
dards or the addition of other ingredients should be 
evaluated with regard to safety and possible benefits fol-
lowing current scientific standards, usually including 
clinical trials  [1, 22–24] . Documentation of the safety of 
an ingredient or compositional concept in IF usually but 
not always can be extrapolated to FUF, whereas benefit 
usually should be demonstrated specifically for the age 
periods in which IF or FUF are used.
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